- US-listed companies
- Eton Pharmaceuticals, Inc.
- Balance sheet
Eton Pharmaceuticals, Inc. (ETON) Balance sheet
Market cap
$847.17M
P/E ratio
| 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 27 | 12 | 21 | 14 | 16 | 21 | 15 |
| Total cash & short-term investments | 27 | 12 | 21 | 14 | 16 | 21 | 15 |
| Accounts receivable, net | - | 0 | 0 | 5 | 2 | 3 | 5 |
| Inventories | - | 0 | 1 | 1 | 1 | 1 | 15 |
| Total current assets | 28 | 15 | 25 | 24 | 20 | 27 | 41 |
| Property, plant and equipment, net | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Total non-current assets | 1 | 2 | 2 | 4 | 5 | 5 | 35 |
| Total assets | 28 | 17 | 26 | 27 | 25 | 32 | 76 |
| Accounts payable | 1 | 1 | 2 | 2 | 2 | 2 | 4 |
| Long-term debt, current | - | - | - | 1 | 1 | 5 | - |
| Total current liabilities | 2 | 2 | 4 | 5 | 6 | 16 | 20 |
| Long-term debt, non-current | - | 5 | 7 | 5 | 5 | - | 30 |
| Total non-current liabilities | - | 5 | 7 | 5 | 5 | 0 | 32 |
| Total liabilities | 2 | 7 | 11 | 10 | 12 | 16 | 52 |
| Common stock and paid-in capital | 72 | 75 | 0 | 0 | 0 | 0 | 0 |
| Retained earnings | -46 | -64 | -92 | -94 | -103 | -104 | -108 |
| Stockholders' equity | 26 | 11 | 16 | 18 | 13 | 15 | 24 |
| Total debt | - | 5 | 7 | 7 | 6 | 5 | 30 |
| Net debt | - | -8 | -15 | -8 | -10 | -16 | 15 |
| D/E ratio (%) | - | 43 | 41.7 | 37.9 | 49.1 | 34.8 | 122 |
| Working capital | - |